Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue Decision

Posted on July 16, 2026July 18, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue Decision

Fact Source: Financial Supervisory Service (DART) / 2026-07-16

Disclosure Type: Suspension of Trading in Shares

💡 3-Second Summary

Alteogen’s common shares were temporarily suspended from trading from 3:31 PM on July 16, 2026, until the close of the market on the same day, following the regulatory filing of its bonus issue decision.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Target Security: Alteogen Common Shares
  • Reason for Suspension: Bonus Issue
  • Suspension Period:
    • Start Date & Time: July 16, 2026, at 15:31:00 KST
    • End Date & Time: Until the close of the market on July 16, 2026
  • Governing Rules: Article 37 of the KOSDAQ Market Disclosure Regulations and Article 18 of the Enforcement Rules of the same Regulations.
  • Other Key Provisions:
    • Pursuant to Article 26 of the Enforcement Rules of the KOSDAQ Market Operational Regulations, pre-market off-hours trading will not be executed on the day trading resumes.
    • [Derivatives Market] If futures or options linked to the underlying common shares are listed, the corresponding derivatives will also be suspended from trading simultaneously.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

  • Temporary Regulatory Action on Bonus Issue Filing: This disclosure formally registers that the Korea Exchange (KRX) suspended trading in Alteogen’s common shares from 3:31 PM until the close of the market on July 16, following the release of the company’s bonus issue announcement.
  • Restriction on Pre-Market Trading for Resumption Day: The filing clarifies that, under market enforcement rules, pre-market off-hours transactions are prohibited from executing on the day when the trading suspension is officially lifted.
  • No Financial Performance Causes Specified: This regulatory notice reports the administrative suspension of stock trading. It does not contain any details or causes regarding the company’s financial performance or historical earnings results.

📝 Editor’s Comment (by K-STOCK Editor)

Alteogen’s latest disclosure confirms that trading of its common shares, along with any linked listed futures and options in the derivatives market, was suspended on July 16 from 3:31 PM KST until the market close on the same day, triggered by its bonus issue decision.

For investors reviewing this notice, the primary operational checkpoint is the ‘trading mechanics on the day of resumption.’ Pursuant to KOSDAQ market regulations, pre-market off-hours trading is explicitly prohibited on the day trading resumes, meaning that executable orders will only begin with the commencement of the regular session. Investors should verify the overall progress of the core bonus issue timeline while tracking the resumption of the regular trading session in subsequent market data factually.

📢 Disclaimer & Source Information

Source: This content was restructured and newly drafted based on the official submitted data from the Financial Supervisory Service (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred Share
Next Post: [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI Market

Related Posts

[Disclosure] Samsung Biologics Announces Adjustments to Stock Futures & Options Final Trading Day Due to Corporate Split (207940) Disclosures
[Disclosure] Jusung Engineering (036930) Approves Material Split-off of Display/Solar Units; Appoints Appraisal Rights at KRW 35,305 per Share Semiconductors
[Disclosure] Hanwha Ocean (042660) Announces US Subsidiary to Participate in Establishing Shipping Entity ‘Hanwha Shipping LLC’ Disclosures
[Disclosure] Celltrion (068270) Decides to Acquire 492,611 Treasury Shares Worth Approx. KRW 100B on Market for Stock Price Stabilization and Boosting Shareholder Value Disclosures
[Disclosure] SK square (402340) Finalizes Permanent Cancellation of 4.23M Treasury Shares and Re-listing: Proving Gold-Standard Corporate Value-Up Execution Semiconductors
[Disclosure] Hanwha Aerospace (012450) Finalizes Capital Increase Timeline, Amends Share Volume and Ratios Following Third-Party Payment Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme